Abstract:Objectives This study aimed to investigate the relationship between human papillomavirus type 16 (HPV16) and expression of cyclooxygenase-2 (COX-2), P53 in esophageal squamous cell carcinoma (ESCC), which has not yet been elucidated.Methods HPV16 was detected by amplifying the HPV16 E6 gene by the PCR method, and the expression of COX-2, P53 protein in 69 ESCCs and 32 normal esophageal mucosa (NEM) from Shaanxi Province was examined by the streptavidin-peroxidase method. Estimation of overall survival by HPV16, COX-2, and P53 was calculated with the Kaplan-Meier method and analyzed with the log-rank test.Results The infection rate of HPV16 in ESCCs (35 of 69, 50.7%) was significantly higher than that in NEMs (two of 32, 6.25%) (P<0.01). The expression rate of COX-2 in ESCCs (44 of 69, 63.8%) was higher than that in NEMs (two of 32, 6.25%) (P<0.01). The expression intensity of COX-2 expression had statistical difference in histological grade (R = 0.4453, P = 0.0019), tumor stage (R = 0.438, P = 0.000), and metastasis (R = 0.417, P = 0.002). P53 expression rate was 49.3% (34 of 69) in ESCC and 18.8% (six of 32) in NEMs. The expression rate of P53 proteins in ESCC was statistically higher than that in N67EMs (P = 0.0037). The infection of HPV16 had inverse correlation with the overexpression of COX-2 in ESCCs (R = -0.321, P = 0.008). The HPV16 DNA in ESCC had no statistical correlation with P53 protein (R = -0.014, P = 0.9055) and the elevated expression of COX-2 had positive correlation with P53 protein in ESCC (R = 0.441, P = 0.000). No statistical correlation was observed between the infection of HPV16 and clinicopathological features in ESCCs including sex, age, tumor stage, and lymph node metastasis, respectively (P>0.05). The COX-2 had no statistical correlation with sex and age (P>0.05), but had association with tumor stage and lymph node metastasis, respectively (P<0.05). The expression of P53 protein had significant association with lymph node metastasis (P = 0.0005), but not with sex, age, and tumor stage, respectively (P>0.05). The overexpression of COX-2, infection of HPV16, and P53 protein in ESCC were not correlated with survival during the 5-year follow-up period (P>0.05).Conclusion We first concluded that the increased expression of COX-2 had inverse correlation with HPV16 in ESCC. COX-2, HPV16, and P53 had no significant-effect on the survival of patients with ESCC. These observations might help us to further understand the significant association between HPV16 and other molecules involved in the carcinogenesis and progression of ESCC. Eur J Gastroenterol Hepatol 22:67-74 (C) 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins.

Elevated P53 Expression Levels Correlate with Tumor Progression and Poor Prognosis in Patients Exhibiting Esophageal Squamous Cell Carcinoma.

[Expression of Fas, Fas Ligand, Fas-associated Death Domain Protein, Caspase 8 and Mutant P53 Protein in Esophageal Squamous Cell Carcinoma].

The clinical significance of p53 and pRb signal pathway in esophageal cancer patients

Expression of MDR1mRNA detected and its correlation with p53 in esophageal carcinoma by in situ hybridization

The High Expression of p53 Is Predictive of Poor Survival Rather TP53 Mutation in Esophageal Squamous Cell Carcinoma

Abnormal P16 Expression and Prognostic Significance in Esophageal Squamous Cell Carcinoma.

Expression of P-EGFR and P-Akt Protein in Esophageal Squamous Cell Carcinoma and Its Prognosis

High P53 and MAP1 Light Chain 3A Co-Expression Predicts Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma.

Expression of p53 and vascular endothelial growth factor in esophageal squamous cell carcinoma and their clinical significance]

Expression of P53, P16 and Cyclooxygenase-2 in Esophageal Cancer with Tissue Microarray

High Expression of P300 Has an Unfavorable Impact on Survival in Resectable Esophageal Squamous Cell Carcinoma.

Characterization and correlation of 14-3-3σ and P53 protein expressions in multi-stage carcinogenesis of esophageal squamous cell carcinoma

The High Expression Instead of Mutation of P53 is Predictive of Overall Survival in Patients with Esophageal Squamous‐cell Carcinoma: a Meta‐analysis

[A Histopathologic and Immunohistochemical Study of Prognostic Factors in Esophageal Squamous Cell Carcinoma].

Investigation on the Potential Correlation Between TP53 and Esophageal Cancer

Expression and Clinical Significance of Survivin and P63 Protein in Esophageal Squamous Carcinoma

The Relationship Between Hpv16 and Expression of Cyclooxygenase-2, P53 and Their Prognostic Roles in Esophageal Squamous Cell Carcinoma

Expression of VEGF-C correlates with a poor prognosis based on analysis of prognostic factors in 73 patients with esophageal squamous cell carcinomas.

Expression of PD-L1 and its prognostic role in patients with esophageal squamous cell carcinoma

Expressions of p-EGFR and p-Akt proteins in esophageal squamous cell carcinoma tissue

Correlation of 3'-Phosphoadenosine-5'-phosphosulfate Synthase 1 (PAPSS1) Expression with Clinical Parameters and Prognosis in Esophageal Squamous Cell Carcinoma.